Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Operating Margin

Below are the top drugs-generic stocks on the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co Inc

is 33.13%. HITK's revenue for the same period is $219.97 million. The trailing-twelve-month operating margin at Salix Pharmaceuticals Ltd

is 25.63%. SLXP's ROE for the same period is 18.41%. The trailing-twelve-month operating margin at Akorn Inc

is 21.78%. AKRX's PEG ratio is 0.80. The trailing-twelve-month operating margin at Mylan Inc

is 16.95%. MYL's revenue for the same period is $6.03 billion.